Interleukin 2 News and Research

RSS
Oxford-AstraZeneca COVID-19 vaccine induces robust T cell-based immunity

Oxford-AstraZeneca COVID-19 vaccine induces robust T cell-based immunity

The role of natural killer cells in fight against viral infections including SARS-CoV-2

The role of natural killer cells in fight against viral infections including SARS-CoV-2

SARS-CoV-2 oral vaccine booster shows promise in animal tests

SARS-CoV-2 oral vaccine booster shows promise in animal tests

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

Circular RNA vaccine shows neutralizing activity against B.1.351 variant

Circular RNA vaccine shows neutralizing activity against B.1.351 variant

First patient participates in immunotherapy trial despite COVID-19 pandemic

First patient participates in immunotherapy trial despite COVID-19 pandemic

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Highly functional immune response in asymptomatic SARS-CoV-2 infection

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

New type of immunotherapy shows promise for advanced skin cancer

New type of immunotherapy shows promise for advanced skin cancer

MU offers an alternative to chemotherapy for treatment of cancer in animals and humans

MU offers an alternative to chemotherapy for treatment of cancer in animals and humans

Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19

Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Study identifies possible factors to predict severe toxicities in CAR T patients

Study identifies possible factors to predict severe toxicities in CAR T patients

Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients

Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients

Tobacco smoking and vaping nicotine may exacerbate COVID-19 inflammation

Tobacco smoking and vaping nicotine may exacerbate COVID-19 inflammation

Drug associated with lower mortality in mechanically ventilated COVID-19 patients

Drug associated with lower mortality in mechanically ventilated COVID-19 patients

First extensive review of COVID-19's effects on all affected organs outside the lungs

First extensive review of COVID-19's effects on all affected organs outside the lungs

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

New method helps pinpoint new potential therapeutic targets for lupus

New method helps pinpoint new potential therapeutic targets for lupus